956 results on '"Jensen, Lisette Okkels"'
Search Results
202. Coronary stent implantation and adverse cardiac events after surgery
203. One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis
204. Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
205. 3-year Clinical Outcomes of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Acute Coronary Syndroms (a SORT OUT VI Substudy)
206. 3-year Clinical Outcomes of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Diabetes Mellitus (a SORT OUT VI Substudy)
207. Five-year risk of target lesion revascularization in patients with and without an acute coronary syndrome treated with drug-eluting stents:a pooled analysis of individual participant data from three randomized SORT OUT trials
208. Influence of 12-month Late Incomplete Stent Apposition after Biolimus-eluting and Sirolimus-eluting Stent Implantation on 5-year Clinical Outcomes Following ST-segment Elevation Myocardial Infarction:Insigths from the SORT OUT V Trial Intravascular Ultrasound Substudy
209. Ten-year All-cause Mortality after Simple versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study
210. Two-year outcomes after revascularization with a biodegradable polymer ultra-thin strut sirolimus eluting stent and a biodegradable polymer biolimus-eluting stent. From the SORT OUT VII trial
211. Impact of Late Acquired Malapposition after Biolimus-eluting and Sirolimus-eluting Stent Implantation on 5-year Clinical Outcomes Following ST-segment Elevation Myocardial Infarction:Intravascular Ultrasound Analysis from the SORT OUT V Trial
212. Impact of diabetes on clinical outcomes after revascularization with sirolimus‐eluting and biolimus‐eluting stents with biodegradable polymer from the SORT OUT VII trial
213. TCT-90 Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII trial.
214. TCT-347 Culprit Lesion Types and Vascular Healing in Patients with ST-segment Elevation Myocardial Infarction after Primary Percutaneous Intervention
215. TCT-792 Everolimus-eluting versus biolimus-eluting stent implantation in unselected patients with and without diabetes: a SORT OUT VIII substudy
216. TCT-737 Very Late Stent Thrombosis after Revascularization with Biodegradable Polymer Drug-Eluting Stents. From the SORT OUT VII Trial
217. TCT-793 10-year outcomes in patients with and without diabetes treated with first-generation zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study
218. Validation of the European Society of Cardiology and European Society of Anaesthesiology non-cardiac surgery risk score in patients treated with coronary drug-eluting stent implantation
219. Uncovered Culprit Plaque Ruptures in Patients With ST-Segment Elevation Myocardial Infarction Assessed by Optical Coherence Tomography and Intravascular Ultrasound With iMap
220. Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest
221. Stent implantation and vascular healing of a spontaneous coronary artery dissection assessed by optical coherence tomography in a patient with acute coronary syndrome
222. How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?
223. Data on association between QRS duration on prehospital ECG and mortality in patients with confirmed STEMI
224. Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction
225. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock
226. Long-term prognosis of patients with non-ST-segment elevation myocardial infarction according to coronary arteries atherosclerosis extent on coronary angiography: a historical cohort study
227. Rapid Pacing Using the Guidewire During Transcatheter Tricuspid Valve in Valve Implantation
228. False Negative Echocardiography in an Adolescent with Anomalous Left Main Coronary Artery Origin Presenting with Cardiac Arrest
229. Do We Need to Stent Arterial Duct in Hybrid Approach for Hypoplastic Left Heart Syndrome?
230. TCT-730 Five-year risk of target lesion revascularization in patients with and without an acute coronary syndrome treated with drug-eluting stents: a pooled analysis of individual participant data from three randomized SORT OUT trials
231. TCT-324 Rehospitalization after percutaneous coronary intervention
232. TCT-740 3-year Clinical Outcomes of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Acute Coronary Syndroms (a SORT OUT VI Substudy)
233. TCT-250 3-year Clinical Outcomes of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients with Diabetes Mellitus (a SORT OUT VI Substudy)
234. TCT-758 Influence of Gender Differences on Invasive Coronary Microvascular and Flow Measurements in Patients with Stable Angina
235. Invasively measured aortic systolic blood pressure and office systolic blood pressure in cardiovascular risk assessment
236. Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents:5-Year Results From SORT OUT IV
237. Association of intraoperative transit time flow after grafting and invasive coronary flow and pressure measurements before coronary artery bypass surgery
238. Patient delay in patients with ST-elevation myocardial infarction:time patterns and predictors for a prolonged delay
239. Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer. From the SORT OUT VII Trial
240. Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting. Five Year Clinical Outcome in The Nordic-Baltic Bifurcation Study III
241. Culprit lesion morphology in patients with ST-segment elevation myocardial infarction assessed by optical coherence tomography
242. Coronary artery disease and risk of adverse cardiac events and stroke
243. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation
244. Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients
245. Early restenose in a polymer-free Biolimus A9-coated stent (BioFreedom): A case report based on optical coherence tomography
246. Lipid-core burden response to stent implantation assessed with near-infrared spectroscopy and intravascular ultrasound evaluation in patients with myocardial infarction
247. Distance to invasive heart centre, performance of acute coronary angiography, and angioplasty and associated outcome in out-of-hospital cardiac arrest: a nationwide study
248. Influence of ezetimibe in addition to high-dose atorvastatin therapy on plaque composition in patients with ST-segment elevation myocardial infarction assessed by serial
249. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease
250. A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.